Navigation Links
Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
Date:12/8/2008

IRVINE, Calif., Dec. 8 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions, announces the launch of its Integrated Services Offering for pharmacovigilance as well as significant growth of its Global Professional Services (GPS) organization.

In 2008, Relsys has delivered numerous Argus Safety(TM) upgrade projects, even as it continues to add new system implementations to its portfolio. Chris Jabbal, Chief Services Officer for Relsys, commented: "This year, our GPS organization has increased the number of projects delivered by more than 300% over 2007, with several more projects due to be completed before the end of the year." New safety database implementations in 2008 have included at least three Top 20 pharma companies, as well numerous smaller and mid-sized companies. Jabbal continued: "We have proactively scaled our professional services organization to address the growth in our project portfolio. Our team has doubled in the past year, as we have hired numerous project managers, analysts and subject matter experts. The Relsys GPS team has the capacity to continue to deliver even more new projects in the future."

Relsys has also launched its Integrated Services Offering, focusing on delivering pharma projects on-time, to-plan and to-budget. Jabbal commented: "We have always been focused on delivering end-to-end drug safety solutions to address our clients' pharmacovigilance needs. Our primary vision is to effectively execute the delivery of the Integrated Services Offering to address pharma's pressing safety and risk management needs." To ensure successful execution, Relsys has also implemented a Services Quality Management System (SQMS) -- a quality assurance system for professional services with an explicit goal to increase standards of excellence. "We are very excited about the new programs -- they are an integral part of our vision to become a world-class services organization," said Jabbal.

Interested parties may learn more about the Integrated Service Offerings and SQMS by visiting http://www.relsys.net/services or by contacting us at info@relsys.net.

About Relsys International

Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's widely-used drug safety and adverse event reporting software. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit http://www.relsys.net, or call +1 949-453-1715.


'/>"/>
SOURCE Relsys International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
2. M. D. Anderson to hold first international conference on inflammatory breast cancer
3. Ramsey, N.J. Therapists Lectures to International Medical Professionals & Provides Treatment to Professional Athletes at Home and Abroad
4. NSF International Offers Answers to Rising Toy Safety Concerns
5. PRA International Expands European Presence With Opening of Munich Office
6. International study supports new standard of treatment for women with advanced ovarian cancer
7. UH Rainbow Babies and Childrens Hospital gains international recognition for ECMO treatment
8. Mercy Ships Recognizes International Day of Disabled Persons
9. President George W. Bush Receives International Medal of PEACE That Coincides With PEPFAR Milestone on World Aids Day:
10. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
11. International Medical Corps Launches Online Catalog Offering Gifts That Save the Lives of Those in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s spiritual ... published author, Julianne Hale, a consultant for the Intelligence Community. For more ... on the Near East region. Julianne has written hundreds of reports for ...
(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class ... Fatigue . , As the stress of modern life continually makes more demands on ... use of artificial stimulants can trap people in vicious high/low cycles and can also ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that provides online ... with physicians and advanced practitioners like nurse practitioners and physician assistants ... through November of this year. The online career fairs will allow job seekers to ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los Angeles area medical ... for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. This ... Plastic and Reconstructive Surgery. The candidate will have the opportunity to work ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local ... for Alzheimer’s Family Center. , Guests will be able to vote for their ... Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... WARSAW, Ind. , Aug. 7, 2017 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the third quarter of 2017. ... will be paid on or about October 27, 2017 to ... September 22, 2017.  Future declarations of dividends are subject to ...
Breaking Medicine Technology: